Schizophrenia Cognition Scale Development

NCT02118571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2025-02-12

No results posted yet for this study

Summary

The objective of this protocol is to develop items for a patient-reported outcome (PRO) measure to assess the patient's perspective and subjective experience of cognitive impairment associated with schizophrenia (CIAS).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Raymond C Rosen, PhD · New England Research Institutes, Inc.

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02118571 on ClinicalTrials.gov